Medicine and Dentistry
Biological Marker
83%
Heart Failure
80%
Cardiovascular Disease
61%
Natriuretic Factor
40%
Cardiovascular System
37%
Atrial Fibrillation
34%
Brain Natriuretic Peptide
32%
Cardiovascular Risk
29%
Amino Terminal Sequence
28%
Disease
26%
Blood Pressure
25%
Hazard Ratio
25%
Body Mass Index
24%
Diabetes
24%
C Reactive Protein
21%
Child
20%
Ischemic Heart Disease
18%
Apoplexy
16%
Odds Ratio
14%
Metabolite
14%
Cohort Analysis
14%
Systolic Blood Pressure
13%
Atherosclerosis
13%
Vitamin D
12%
Left Ventricular Hypertrophy
12%
Prevalence
12%
Growth Differentiation Factor 15
12%
Insulin Resistance
11%
Aldosterone
10%
Sodium Chloride
10%
Cohort Effect
10%
Echocardiography
10%
Left Ventricular Systolic Dysfunction
10%
Study Participant
10%
Congestive Heart Failure
9%
Meta-Analysis
9%
Heart Failure with Preserved Ejection Fraction
9%
Myocardial Infarction
9%
Plasminogen Activator Inhibitor-1
8%
Arterial Stiffness
8%
QRS Interval
8%
Ejection Fraction
8%
Atrial Natriuretic Factor
8%
Metabolic Syndrome
8%
Obesity
7%
Metabolomics
7%
Heart Failure with Reduced Ejection Fraction
7%
Race Difference
7%
Diabetes Mellitus
7%
Nonalcoholic Fatty Liver
7%
Biochemistry, Genetics and Molecular Biology
Natriuretic Peptide
100%
Metabolite
50%
Blood Pressure
48%
N-Terminus
37%
C-Reactive Protein
31%
Genetics
31%
Vitamin D
30%
Atrial Fibrillation
29%
Body Mass
28%
Proteomics
27%
Metabolomics
26%
Progeny
26%
Systolic Blood Pressure
21%
Aldosterone
20%
Genome-Wide Association Study
20%
Genetic Divergence
19%
Single-Nucleotide Polymorphism
18%
Insulin Resistance
17%
Atrial Natriuretic Peptide
17%
Plasminogen Activator Inhibitor-1
16%
Growth Differentiation Factor
16%
Cohort Study
16%
Renin
16%
Amino Acids
15%
Heart Ejection Fraction
15%
Creatinine
15%
Diastolic Blood Pressure
13%
Allele
12%
Homocysteine
12%
Blood Level
11%
Biomarker Discovery
10%
Single Nucleotide Polymorphism
10%
Aptamer
10%
Proteome
9%
Heart Left Ventricle Mass
9%
Renin Angiotensin Aldosterone System
9%
Metabolic Pathway
9%
Troponin I
9%
Prevalence
9%
Lipid
8%
Genetic Architecture
8%
Fibrinogen
8%
All Cause Mortality
8%
Prospective Study
8%
Triglyceride
8%
Metabolome
7%
Glomerulus Filtration
7%
Brain Natriuretic Peptide
7%
Kidney Function
7%
Genotyping
7%
Keyphrases
Heart Failure
57%
Framingham Heart Study
46%
Cardiovascular Disease
40%
Cardiovascular Risk
36%
Natriuretic Peptides
35%
Confidence Interval
34%
Atrial Fibrillation
27%
Hypertension
23%
B-type Natriuretic Peptide
22%
Hazard Ratio
21%
Obesity
20%
Risk Factors
18%
Multivariable
17%
Blood Pressure
17%
Incident Heart Failure
17%
C-reactive Protein
17%
Soluble Suppression of Tumorigenicity 2 (sST2)
16%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
13%
Vitamin D Status
12%
Atrial Natriuretic Peptide
12%
Heart Failure Risk
12%
Cardiovascular Mortality
12%
Diabetes
11%
Vitamin D
11%
Vitamin D Deficiency
11%
Growth Differentiation factor-15 (GDF-15)
11%
Cardiovascular Events
11%
Coronary Artery Disease
11%
Insulin Resistance
10%
Framingham Offspring Study
9%
Cardiovascular Biomarkers
9%
Left Ventricular Mass
9%
Metabolic Profiling
9%
Epidemiology
9%
Vitamin D Supplementation
8%
Cardiometabolic Risk
8%
Congestive Heart Failure
8%
25-hydroxyvitamin D (25OHD)
8%
Peptide Concentration
8%
Myocardial Infarction
8%
Insulin
8%
New Biomarkers
8%
Cardiometabolic Disease
8%
Genetic Variants
7%
Left Ventricular Hypertrophy
7%
Circulating Biomarkers
7%
Community-based Sample
7%
Multiple Biomarkers
7%
African American
7%
